4-氯-2-甲氧基苯甲酸甲酯 | 78955-90-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯-2-甲氧基苯甲酸甲酯
• 中文别名: 4-氯-2-甲氧基-苯甲酸甲酯
• 英文名称: methyl 4-chloro-2-methoxybenzoate
• CAS: 78955-90-5
• 化学式: C₉H₉ClO₃
• 分子量: 200.622
• InChiKey: UTEXPQWKBMXWJD-UHFFFAOYSA-N

物化性质

• 熔点：
  36 °C
• 沸点：
  271.4±20.0 °C(Predicted)
• 密度：
  1.228±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2918990090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312+P330,P302+P352+P312,P304+P340+P312,P305+P351+P338,P332+P313,P337+P313,P362,P363,P403+P233,P405,P501
• 危险性描述：
  H302+H312+H332,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 4-chloro-2-methoxybenzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 4-chloro-2-methoxybenzoate
CAS number: 78955-90-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9ClO3
Molecular weight: 200.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  4-氯-2-甲氧基苯甲酸	2-methoxy-4-chlorobenzoic acid	57479-70-6	C8H7ClO3	186.595
  4-氯-2-羟基苯甲酸甲酯	methyl 4-chloro-2-hydroxybenzoate	22717-55-1	C8H7ClO3	186.595
  4-氯水杨酸	4-chlorosalicylic acid	5106-98-9	C7H5ClO3	172.568

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  4-氯-2-甲氧基苯甲酸	2-methoxy-4-chlorobenzoic acid	57479-70-6	C8H7ClO3	186.595
  4-氯-2-甲氧基苄醇	(4-chloro-2-methoxy-phenyl)methanol	90296-27-8	C8H9ClO2	172.611
  4-氯-2-甲氧基苯甲醛	4-chloro-2-methoxybenzaldehyde	53581-86-5	C8H7ClO2	170.595
  ——	methyl 4-ethyl-2-methoxybenzoate	902137-24-0	C11H14O3	194.23
  4-氰基-2-甲氧基苯甲酸甲酯	methyl 4-cyano-2-methoxybenzoate	406719-76-4	C10H9NO3	191.186
  3-甲氧基-[1,1-联苯]-4-羧酸甲酯	methyl 3-methoxy-[1,1'-biphenyl]-4-carboxylate	175152-70-2	C15H14O3	242.274
  2-甲氧基-4-氯苯甲酰氯	4-chloro-2-anisoyl chloride	5607-64-7	C8H6Cl2O2	205.04
  ——	4-chloro-2-methoxybenzohydrazide	878465-96-4	C8H9ClN2O2	200.625
  3-甲氧基-[1,1-联苯]-4-羧酸	3-(methyloxy)-4-biphenylcarboxylic acid	175153-18-1	C14H12O3	228.247

反应信息

• 作为反应物：
  描述：

  4-氯-2-甲氧基苯甲酸甲酯 在 氯化亚砜 、 水 作用下， 以 二氯甲烷 为溶剂， 反应 1.25h， 生成 2-甲氧基-4-氯苯甲酰氯
  参考文献：
  名称：

  3'，4'，5'-三甲氧基黄酮类水杨酸酯衍生物作为潜在抗肿瘤药的设计，合成和初步生物学评估†

  摘要：

  根据药效团结合原理，设计，合成了一组新的3'，4'，5'-三甲氧基黄酮类水杨酸酯衍生物，并对其生物学活性进行了评估。细胞毒性评估表明，化合物10v对HCT-116细胞显示出比5-Fu更高的效价。初步的生物学活性研究表明，化合物10v可以抑制HCT-116细胞的集落形成和迁移。此外，Hoechst 33258染色测定法和流式细胞仪显示用化合物10v治疗诱导HCT-116细胞的凋亡呈浓度依赖性，但对它们的细胞周期无影响。WB分析表明，HIF-1α，微管蛋白，HK-2和PFK可能是化合物10v的潜在药效团靶标。微管蛋白是化合物10v的潜在药物靶标，这是通过分析与微管蛋白复合的化合物10v的晶体结构来解释的。这些结果表明，化合物10v可能是有前途的抗肿瘤药物候选物，值得进一步优化和评估。

  DOI：

  10.1039/c8nj04533j
• 作为产物：
  描述：

  ethyl (E)-3-(4-chloro-2-methoxyphenyl)acrylate 生成 4-氯-2-甲氧基苯甲酸甲酯
  参考文献：
  名称：

  Pyrrole derivatives

  摘要：

  以下是用中文翻译的结果： 由以下公式表示的吡咯衍生物： 其中环Z是可选择取代的吡咯环等；W 2 是—CO—，—SO 2 —，可选择取代的C 1 -C 4 烷基等；Ar 2 是可选择取代的芳基等；W 2 和Ar 1 表示如下（1）和（2）： （1）W 1 是可选择取代的C 1 -C 4 烷基等；Ar 1 是具有1至4个氮原子作为环形成原子的可选择取代的双环杂芳基： （2）W 1 是可选择取代的C 2 -C 5 烷基，可选择取代的C 2 -C 5 烯基等；Ar 1 是芳基或单环杂芳基，其在与W 1 的结合位置相对应的邻位或间位处被羧基，烷氧羰基等取代， 或其药学上可接受的盐 这些化合物可用作器官或组织的纤维化抑制剂等药物。

  公开号：

  US20030181496A1
• 作为试剂：
  描述：

  4-氯-2-甲氧基苯甲酸 、 4,5-二氟苯-1,2-二胺 、 在 4-氯-2-甲氧基苯甲酸甲酯 、 4,5-二氟苯-1,2-二胺 、 乙酸乙酯 、 Sodium sulfate-III 、 silica gel 、 ethyl acetate n-hexane 作用下， 以 polyphosphoric acid 为溶剂， 反应 1.0h， 以to give the desired compound as a brown solid (77%)的产率得到2-(4-chloro-2-methoxy-phenyl)-5,6-difluoro-1H-benzoimidazole
  参考文献：
  名称：

  Benzimidazole derivatives

  摘要：

  本发明涉及式(I)化合物，以及其药学上可接受的盐，可以以制药组合物的形式使用，其中A、B、R1、R2、R3、R4、R5、n、m和p具有在此定义的意义。

  公开号：

  US08309581B2

文献信息

• FIBROSIS INHIBITOR
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：EP1479384A1

  公开（公告）日：2004-11-24

  Medicament being useful as a fibrosis inhibitor for organs or tissues, which comprises a compound of the formula (I): wherein Ring Z is optionally substituted pyrrole ring, etc.; W2 is -CO-, -SO2-, optionally substituted C1-C4 alkylene, etc.; Ar2 is optionally substituted aryl, etc.; W1 and Ar1 mean the following (1) and (2): (1) W1 is optionally substituted C1-C4 alkylene, etc.; Ar1 is optionally substituted bicyclic heteroaryl having 1 to 4 nitrogen atoms as ring-forming atoms: (2) W1 is optionally substituted C2-C5 alkylene, optionally substituted C2-C5 alkenylene, etc.; and Ar1 is aryl or monocyclic heteroaryl, which is substituted by carboxyl, alkoxycarbonyl, etc. at the ortho- or meta-position thereof with respect to the binding position of W1, or a pharmaceutically acceptable salt thereof.

  药物作为器官或组织的纤维化抑制剂而有用，包括具有以下式（I）的化合物： 其中环Z是可选择取代的吡咯环等；W2是-CO-，-SO2-，可选择取代的C1-C4烷基等；Ar2是可选择取代的芳基等；W1和Ar1表示如下（1）和（2）： （1）W1是可选择取代的C1-C4烷基等；Ar1是可选择取代的具有1至4个氮原子作为环形成原子的双环杂芳基： （2）W1是可选择取代的C2-C5烷基，可选择取代的C2-C5烯基等；以及 Ar1是芳基或单环杂芳基，其在相对于W1的结合位置的邻位或间位处被羧基，烷氧羰基等取代， 或其药学上可接受的盐。
• SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW MEDICAMENT FOR FIBROSIS, AUTOPHAGY AND CATHEPSINS B (CTSB), L (CTSL) AND D (CTSD) RELATED DISEASES
  申请人：Genoscience Pharma SAS

  公开号：EP3620164A1

  公开（公告）日：2020-03-11

  The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention can be useful as a medicament in the treatment and/or the decreasing and/or the prevention of fibrosis and/or fibrosis related diseases, or for use as a medicament in the treatment and/or the decreasing and/or the prevention of the autophagy and/or autophagy related diseases and for the inhibition of the autophagy flux, or for use in the inhibition of cathepsins B (CTSB), L (CTSL) and/or D (CTSD) and/or cathepsins B (CTSB), L (CTSL) and/or D (CTSD) related diseases; with the proviso that said compounds are not to be used for the treatment of any forms of cancers.

  本发明涉及新型2-初级氨基-4-次级氨基喹啉衍生物，其制备方法，包含它们的药物组合物以及它们作为药物的用途。本发明的活性化合物可用作药物治疗和/或减少和/或预防纤维化和/或与纤维化相关疾病，或用作药物治疗和/或减少和/或预防自噬和/或与自噬相关疾病以及抑制自噬通量，或用于抑制蛋白酶B（CTSB）、L（CTSL）和/或D（CTSD）和/或与蛋白酶B（CTSB）、L（CTSL）和/或D（CTSD）相关疾病；但所述化合物不得用于治疗任何形式的癌症。
• METHOD FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOX-AMIDE AND THE PURIFICATION THEREOF FOR USE AS AN ACTIVE PHARMACEUTICAL INGREDIENT
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20170217957A1

  公开（公告）日：2017-08-03

  The present invention relates to a novel and improved process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (I) and also the preparation and use of the crystalline polymorph I of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (I).

  本发明涉及一种用于制备（4S）-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酰胺（I）的新型和改进的工艺，以及（4S）-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酰胺（I）的结晶多型体I的制备和使用。
• [EN] HETEROCYCLIC KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE HETEROCYCLIQUE
  申请人：ABBOTT LAB

  公开号：WO2004076424A1

  公开（公告）日：2004-09-10

  Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有公式(I)的化合物对于抑制蛋白激酶是有用的。还公开了制造这些化合物的方法、包含这些化合物的组合物以及使用这些化合物的治疗方法。
• Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
  申请人：Tachdjian Catherine

  公开号：US20060263411A1

  公开（公告）日：2006-11-23

  The inventions disclosed herein relate to the discovery of the use of compounds having the formula shown below and certain subgenera or species thereof, as flavor or taste modifiers, particularly, savory (“umami”) taste modifiers, savory flavoring agents and savory flavor enhancers in foods, beverages, and other comestible compositions.

  本发明涉及发现具有如下所示公式化合物的使用，以及其中某些子属或物种，作为风味或口味修饰剂，特别是，用于食品、饮料和其他可食用组合物的肉类（“鲜味”）口味修饰剂、肉类风味剂和肉类风味增强剂。